Pimafukort ointment d / nar. approx. tube 15g # 1
Category
Antifungal
Scope of the drug
Leather
Release form
Ointment
Manufacturer country
Italy
Package quantity, pcs
one
Release form, composition and packaging Ointment for external use from white to yellow.
1 g
natamycin
10 mg
neomycin (as sulfate)
3500 units
hydrocortisone micronized
10 mg
polyethylene ointment base (95% liquid paraffin, 5% polyethylene).
15 g - aluminum tubes (1) - cardboard packs. 15 g - plastic tubes (1) - cardboard packs.
Name ENG
PIMAFUCORT
Clinical and pharmacological group
Drug with antibacterial, antifungal and anti-inflammatory action for external use
ATX code
Hydrocortisone in combination with antibiotics
Dosage
10mg / g + 10mg / g + 3500 units / g x 15g
Structure
1 g: - Natamycin 10 mg.
- neomycin (in the form of neomycin sulfate) 3500 IU.
- micronized hydrocortisone 10 mg.
Excipients: Polyethylene ointment base (95% liquid paraffin, 5% polyethylene) 976.5 mg.
Indications
Dermatoses amenable to glucocorticosteroid therapy, complicated by a secondary bacterial and / or fungal infection (especially caused by Candida fungi).
INN / Active ingredient
hydrocortisone, neomycin (as sulfate), natamycin
Contraindications
You should not include Pimafucort cream or ointment in the course of conservative treatment if you have:
,
individual hypersensitivity or intolerance to the components of the pharmaceutical preparation
cutaneous form of syphilis
rosacea (popularly simply rosacea") - a chronic disease with lesions of the skin of the face due to angioedema and recurrent course
ichthyosis (or diffuse keratoma) is a congenital pathology of increased keratinization of the dermis and its appendages
anogenital itching - unpleasant sensations of discomfort in the genital area and anus
tuberculosis with a predominant lesion of the skin (extrapulmonary form of the disease)
acne (acne vulgaris), regardless of the etiological factor
skin reactions after injections
skin diseases of oncological origin
viral lesions of the integument
side effects from taking pharmaceuticals of the corticosteroid group - perioral dermatitis or striae (striped atrophoderma - stretching of the skin in the form of white or purple stripes) on the body surface
increased fragility of blood vessels of the skin, especially at the site of treatment with the drug.
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 5 years
Specifications
Category
Antifungal
Scope of the drug
Leather
Release form
Ointment
Manufacturer country
Italy
Package quantity, pcs
one
Minimum age from
1 year
Way of introduction
On the skin
Vacation conditions
Without recipe
Brand name
ASTELLAS
The amount of the dosage form in the primary package
15 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D07CA01 Hydrocortisone, in combination with antibiotics
Dosage form
Ointment for external use
Dosage (volume) of the substance in the preparation
10 mg + 10 mg + 3500 IU
The target audience
Children
Expiration date in days
1825
Package weight, g
twenty
Mode of application
:
For adults and children, Pimafukort is applied to the affected skin 2-4 times a day.
The duration of treatment is determined individually, taking into account the nature of the disease, the course of treatment usually does not exceed 14 days.
< br> In children, the drug should be applied to limited areas of the skin, do not use occlusive dressings.
If there is no improvement in the condition in children and adults after 14 days, you should consult a doctor.
< br> In the form of a cream, the drug is recommended for the treatment of acute and subacute dermatoses, incl.
accompanied by weeping.
The ointment is intended for the treatment of subacute and chronic dermatoses, especially in the presence of severe dry skin, lichenification, seborrhea, or in cases where the occlusive properties of the ointment are required.
Pharmaco-therapeutic group
:
Topical glucocorticosteroid + aminoglycoside antibiotic + antifungal agent
"